\n
![\"EarthSnap\"\/](\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2025\/09\/earthsnap-banner-news.webp.webp\")
\n<\/a><\/p>\n
Study lead author Alan Davis is an associate professor and director of the Center for Psychedelic Drug Research and Education<\/a> at The Ohio State University.<\/p>\n \u201cAcross the board \u2013 anxiety<\/a>, depression, global functioning, self-reported depression \u2013 we kept seeing the same signal of continued improvement,\u201d said Davis.<\/p>\n The follow-up results offer a rare long view of outcomes after psychedelic-assisted therapy, an area where long-term data are still sparse.<\/p>\n Understanding psilocybin \u2013 the basics<\/p>\n Psilocybin is a natural compound found in certain mushrooms, often called \u201cmagic mushrooms.\u201d When you ingest psilocybin, your body quickly converts it into psilocin, the active form that interacts with your brain. <\/p>\n Psilocin closely resembles serotonin<\/a>, a key neurotransmitter, so it binds to serotonin receptors \u2013 especially the 5-HT2A receptor. <\/p>\n This binding alters the way nerve cells communicate, which leads to changes in perception, mood, and thought patterns. <\/p>\n From a scientific standpoint, psilocybin disrupts the brain\u2019s usual patterns of activity and connectivity. <\/p>\n Brain imaging studies show that it quiets the \u201cdefault mode network,\u201d a system linked to self-reflection and the inner voice we all carry. <\/p>\n At the same time, it boosts communication between brain regions that don\u2019t normally interact.<\/p>\n Curing depression with psilocybin<\/p>\n The peer-reviewed study, published in 2021, enrolled adults with major depressive disorder and compared two groups: one received psilocybin treatment immediately, and the other started after a wait-list period.<\/p>\n All the participants ultimately completed a standardized protocol: two dosing sessions with psilocybin paired with about 13 hours of psychotherapy<\/a> (including preparation, support during sessions, and integration).<\/p>\n The initial results showed large reductions in depression severity, with half of participants in remission up to one year.<\/p>\n Tracking patients over time<\/p>\n Of the 24 people in the original trial, 18 took part in the five-year check-in. Online questionnaires were used to assess depression, anxiety, and functional impairment. <\/p>\n The researchers also applied a clinician-rated depression scale and conducted qualitative interviews to capture changes the numbers might miss.<\/p>\n The team made a conservative assumption to avoid overstating success. They counted the six who did not return as having fully relapsed to pre-treatment levels.<\/p>\n Even under that assumption, depression scores remained \u201cvery large and significantly\u201d reduced at five years, Davis noted, and the share of participants in complete remission nudged upward.<\/p>\n More than psilocybin<\/p>\n The lasting gains cannot be chalked up solely to the two psilocybin sessions. Only three people reported no additional depression-related treatment in the years since. <\/p>\n Others used antidepressant medications, tried ketamine<\/a> or other psychedelics, or engaged in psychotherapy.<\/p>\n Interviews helped explain that context. Many participants described life with depression as profoundly constricted before the trial \u2013 too little energy, too little hope to engage. <\/p>\n Afterward, several said their depression felt more situational and manageable. They reported a greater capacity for positive emotion and motivation, and a different relationship to low moods when they returned.<\/p>\n A few who experimented with psychedelics on their own found the experiences less helpful without a clinical framework. This underscores a theme from other work by Davis and colleagues: the therapeutic container matters.<\/p>\n A strong alliance with trained therapists, structured preparation, and integration support may play as big a role as the drug itself.<\/p>\n Psilocybin safety over time<\/p>\n At the five-year mark, 11 of 18 participants reported no adverse effects since the trial. Looking back, three remembered feeling unprepared for the heightened emotional sensitivity that followed their dosing sessions. <\/p>\n Two said tapering off medications<\/a> and waiting during the original trial was especially difficult, and two wished they\u2019d had more formal integration therapy afterward.<\/p>\n The study is small, non-randomized at follow-up, and based on a motivated sample \u2013 limitations the authors emphasize.<\/p>\n With just 18 people contributing long-term data, it\u2019s impossible to generalize broadly or disentangle psilocybin\u2019s contribution from other treatments and life changes.<\/p>\n Larger, placebo-controlled trials with systematic follow-up will be needed to test durability, dosing strategies, and who benefits most.<\/p>\n Psilocybin, depression, and healthcare<\/p>\n Even with the study\u2019s limitations, the pattern is encouraging. Many participants maintained remission or continued to function better. <\/p>\n Several described a shift that outlasted symptom scores \u2013 more engagement with family, work, and meaningful activities, and fewer episodes of withdrawal and isolation, which are among depression\u2019s most disabling features.<\/p>\n \u201cFive years later, most people continued to view this treatment as safe, meaningful, and important \u2013 something that catalyzed an ongoing betterment of their life,\u201d Davis said.<\/p>\n \u201cDespite some symptoms coming back, they weren\u2019t experiencing the same levels of impairment \u2013 suggesting this approach might, for some, kick-start lasting positive change.\u201d<\/p>\n The bottom line: psilocybin-assisted therapy remains experimental, and it\u2019s not a depression<\/a> cure-all. But in this small cohort, the combination of guided psychedelic sessions and psychotherapy was associated with durable relief \u2013 and in many cases, a different relationship to depression \u2013 years down the road.<\/p>\n The study is published in the Journal of Psychedelic Studies<\/a>.<\/p>\n \u2014\u2013<\/p>\n Like what you read? Subscribe to our newsletter<\/a> for engaging articles, exclusive content, and the latest updates.\u00a0<\/p>\n Check us out on EarthSnap<\/a>, a free app brought to you by Eric Ralls<\/a> and Earth.com.<\/p>\n \u2014\u2013<\/p>\n","protected":false},"excerpt":{"rendered":"The benefits of psilocybin-assisted therapy for major depression reportedly endures for years, if not forever. In a new…\n","protected":false},"author":2,"featured_media":144163,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[49,48,84,393,394],"class_list":{"0":"post-144162","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-mental-health","8":"tag-ca","9":"tag-canada","10":"tag-health","11":"tag-mental-health","12":"tag-mentalhealth"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/144162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=144162"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/144162\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/144163"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=144162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=144162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=144162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}